BMRN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.84%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $18,013,156.26

BioMarin Pharmaceutical Insider Trading History Chart

BioMarin Pharmaceutical Share Price & Price History

^$91.20

▼ -0.86 (-0.93%)

As of 04/24/2024 06:45 PM ET

Days: 30 | 90 | 365

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

From Paradigm Press | Ad

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

BioMarin Pharmaceutical Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/12/2024	Jean Jacques Bienaime	Director	Sell	20,000	$91.26	$1,825,200.00	474,994
4/10/2024	Erin Burkhart	CAO	Sell	2,286	$90.00	$205,740.00	16,156
3/28/2024	George Eric Davis	EVP	Sell	24,602	$88.34	$2,173,340.68	55,856
3/5/2024	Henry J. Fuchs	Insider	Sell	35,341	$85.18	$3,010,346.38	212,117
3/5/2024	Jean Jacques Bienaime	Director	Sell	1,000	$85.51	$85,510.00	561,203
3/5/2024	Jeffrey Robert Ajer	EVP	Sell	4,000	$87.07	$348,280.00	94,047
2/27/2024	Jean Jacques Bienaime	Director	Sell	1,000	$90.35	$90,350.00	562,203
2/9/2024	Jean Jacques Bienaime	Director	Sell	15,000	$88.28	$1,324,200.00	419,602
1/9/2024	Jean Jacques Bienaime	Director	Sell	10,000	$98.19	$981,900.00	425,162
12/21/2023	Jean Jacques Bienaime	Director	Sell	10,000	$93.99	$939,900.00	425,112
12/13/2023	George Eric Davis	EVP	Sell	13,764	$95.30	$1,311,709.20	55,710
8/16/2023	Jeffrey Robert Ajer	EVP	Sell	5,000	$90.00	$450,000.00	60,804
8/10/2023	Henry J. Fuchs	Insider	Sell	12,000	$90.43	$1,085,160.00	176,187
8/8/2023	George Eric Davis	EVP	Sell	11,000	$89.42	$983,620.00	69,474
8/7/2023	Jean Jacques Bienaime	CEO	Sell	4,000	$88.10	$352,400.00	428,732
5/10/2023	Jean Jacques Bienaime	CEO	Sell	30,000	$94.85	$2,845,500.00	426,213
4/10/2023	Jean Jacques Bienaime	CEO	Sell	10,000	$99.56	$995,600.00	425,896
4/6/2023	Jean Jacques Bienaime	CEO	Sell	10,000	$96.13	$961,300.00	425,896
4/3/2023	V. Bryan Lawlis	Director	Sell	8,500	$97.09	$825,265.00	28,950
3/13/2023	Jean Jacques Bienaime	CEO	Sell	8,000	$90.45	$723,600.00	487,856
3/10/2023	Jean Jacques Bienaime	CEO	Sell	15,000	$92.28	$1,384,200.00	487,856
2/13/2023	Jean Jacques Bienaime	CEO	Sell	6,000	$109.15	$654,900.00	320,324
2/10/2023	Jean Jacques Bienaime	CEO	Sell	15,000	$110.11	$1,651,650.00	320,324
1/25/2023	Jeffrey Robert Ajer	EVP	Sell	49,000	$115.70	$5,669,300.00	41,088
1/17/2023	Jean Jacques Bienaime	CEO	Sell	10,000	$111.55	$1,115,500.00	320,424
1/13/2023	Brian R. Mueller	CFO	Sell	2,500	$114.50	$286,250.00	27,746
1/13/2023	Jean Jacques Bienaime	CEO	Sell	10,000	$112.25	$1,122,500.00	320,424
12/13/2022	Brian R. Mueller	CFO	Sell	2,500	$107.50	$268,750.00	27,746
12/13/2022	Jean Jacques Bienaime	CEO	Sell	1,000	$106.89	$106,890.00	320,424
12/2/2022	Brian R. Mueller	CFO	Sell	7,001	$104.50	$731,604.50	27,746
12/2/2022	Jean Jacques Bienaime	CEO	Sell	1,500	$103.98	$155,970.00	321,424
11/23/2022	Brian R. Mueller	CFO	Sell	5,379	$98.73	$531,068.67	28,847
11/2/2022	Jeffrey Robert Ajer	EVP	Sell	3,000	$86.12	$258,360.00	41,088
10/31/2022	Jean Jacques Bienaime	CEO	Sell	1,500	$86.55	$129,825.00	322,824
10/31/2022	Mark J. Alles	Director	Buy	3,625	$86.75	$314,468.75	10,905
10/14/2022	Jean Jacques Bienaime	CEO	Sell	4,000	$89.89	$359,560.00	324,324
8/15/2022	Jean Jacques Bienaime	CEO	Sell	3,000	$95.21	$285,630.00	328,324
8/12/2022	Jean Jacques Bienaime	CEO	Sell	4,000	$94.75	$379,000.00	331,324
8/11/2022	Jeffrey Robert Ajer	EVP	Sell	3,000	$95.62	$286,860.00	44,088
8/8/2022	Charles Greg Guyer	EVP	Sell	6,205	$96.56	$599,154.80	42,168
7/8/2022	Brian R. Mueller	CFO	Sell	7,337	$89.50	$656,661.50	30,726
7/8/2022	George Eric Davis	EVP	Sell	7,398	$90.00	$665,820.00	58,941
5/26/2022	Jeffrey Robert Ajer	EVP	Sell	1,308	$78.94	$103,253.52	54,109
5/5/2022	Jean Jacques Bienaime	CEO	Sell	10,000	$84.14	$841,400.00	335,324
5/4/2022	Brian R. Mueller	CFO	Sell	11,800	$84.50	$997,100.00	38,639
5/2/2022	George Eric Davis	EVP	Sell	15,347	$80.38	$1,233,591.86	66,339
5/2/2022	Richard A. Meier	Director	Sell	3,878	$82.09	$318,345.02	104,014
4/28/2022	Jean Jacques Bienaime	CEO	Sell	20,000	$83.79	$1,675,800.00	334,983
4/18/2022	Jean Jacques Bienaime	CEO	Sell	20,000	$81.91	$1,638,200.00	334,983
4/14/2022	Jean Jacques Bienaime	CEO	Sell	10,000	$83.66	$836,600.00	334,983
4/14/2022	V. Bryan Lawlis	Director	Sell	4,250	$83.66	$355,555.00	23,970
4/13/2022	Jeffrey Robert Ajer	EVP	Sell	1,180	$82.47	$97,314.60	55,077
3/29/2022	Jeffrey Robert Ajer	EVP	Sell	1,618	$79.43	$128,517.74
3/23/2022	Jeffrey Robert Ajer	EVP	Sell	6,129	$81.78	$501,229.62
3/21/2022	George Eric Davis	EVP	Sell	6,129	$81.29	$498,226.41
3/10/2022	Jean Jacques Bienaime	CEO	Sell	15,000	$77.57	$1,163,550.00
2/28/2022	Dennis Slamon	Director	Sell	6,396	$78.33	$500,998.68
1/14/2022	V. Bryan Lawlis	Director	Sell	4,250	$87.61	$372,342.50
1/13/2022	Jean Jacques Bienaime	CEO	Sell	5,000	$87.86	$439,300.00
12/15/2021	Jean Jacques Bienaime	CEO	Sell	6,000	$82.71	$496,260.00
12/1/2021	Jean Jacques Bienaime	CEO	Sell	1,500	$87.22	$130,830.00
10/26/2021	Jeffrey Robert Ajer	EVP	Sell	2,739	$73.60	$201,590.40
5/10/2021	Jean Jacques Bienaime	CEO	Sell	8,513	$77.29	$657,969.77	312,352
5/7/2021	Brian R. Mueller	CFO	Sell	6,709	$79.50	$533,365.50	31,357
5/7/2021	Jean Jacques Bienaime	CEO	Sell	25,000	$78.12	$1,953,000.00	303,839
5/6/2021	Richard A. Meier	Director	Sell	5,068	$78.38	$397,229.84	99,340
5/3/2021	George Eric Davis	EVP	Sell	4,673	$78.30	$365,895.90	68,781
4/23/2021	Jean Jacques Bienaime	CEO	Sell	10,000	$79.34	$793,400.00	312,498

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

From Paradigm Press | Ad

Click here to find out that this 8,788% cryptocurrency is.

SEC Filings (Institutional Ownership Changes) for BioMarin Pharmaceutical (NASDAQ:BMRN)

98.71% of BioMarin Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BioMarin Pharmaceutical Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/24/2024	Simplicity Wealth LLC	2,958	$0.26M	0.0%	N/A	0.002%
4/24/2024	Assenagon Asset Management S.A.	3,145	$0.28M	0.0%	-81.5%	0.002%
4/23/2024	Rice Hall James & Associates LLC	28,722	$2.51M	0.1%	-2.4%	0.015%
4/22/2024	EFG Asset Management Americas Corp.	19,816	$1.73M	0.5%	-27.2%	0.010%
4/22/2024	IFM Investors Pty Ltd	38,328	$3.35M	0.0%	+0.4%	0.020%
4/19/2024	New Century Financial Group LLC	2,871	$0.25M	0.2%	-39.2%	0.002%
4/19/2024	AMI Asset Management Corp	346,189	$30.24M	1.5%	+51.9%	0.183%
4/19/2024	State of Alaska Department of Revenue	21,095	$1.84M	0.0%	-24.6%	0.011%
4/19/2024	Sumitomo Mitsui Trust Holdings Inc.	477,500	$41.71M	0.0%	-0.9%	0.253%
4/18/2024	Allspring Global Investments Holdings LLC	100,279	$8.76M	0.0%	+65.6%	0.053%
4/18/2024	SteelPeak Wealth LLC	2,498	$0.22M	0.0%	+10.9%	0.001%
4/17/2024	Cannon Global Investment Management LLC	7,800	$0.68M	1.8%	+11.4%	0.004%
4/16/2024	New England Research & Management Inc.	15,350	$1.34M	0.7%	N/A	0.008%
4/16/2024	Capital Insight Partners LLC	2,390	$0.21M	0.0%	N/A	0.001%
4/16/2024	180 Wealth Advisors LLC	2,893	$0.25M	0.0%	-4.5%	0.002%
4/12/2024	Gateway Investment Advisers LLC	21,320	$1.86M	0.0%	+65.2%	0.011%
4/11/2024	Tealwood Asset Management Inc.	12,201	$1.07M	0.5%	-1.8%	0.006%
4/10/2024	Park Avenue Securities LLC	4,620	$0.40M	0.0%	-25.5%	0.002%
4/10/2024	Banque Cantonale Vaudoise	16,350	$1.43M	0.1%	-2.5%	0.009%
3/21/2024	Healthcare of Ontario Pension Plan Trust Fund	53,087	$5.12M	0.0%	N/A	0.028%
3/11/2024	Vanguard Group Inc.	18,050,062	$1.74B	0.0%	+2.0%	9.566%
3/11/2024	Wahed Invest LLC	3,191	$0.31M	0.1%	+10.0%	0.002%
3/6/2024	SageView Advisory Group LLC	2,945	$0.26M	0.0%	N/A	0.002%
3/5/2024	Fisher Asset Management LLC	13,490	$1.30M	0.0%	N/A	0.007%
3/1/2024	Royal London Asset Management Ltd.	73,817	$7.12M	0.0%	+2.7%	0.039%
2/26/2024	Integrated Advisors Network LLC	3,533	$0.34M	0.0%	+6.2%	0.002%
2/26/2024	Teachers Retirement System of The State of Kentucky	163,798	$15.79M	0.1%	-7.8%	0.087%
2/22/2024	Scarborough Advisors LLC	737	$71K	0.0%	N/A	0.000%
2/20/2024	Voisard Asset Management Group Inc.	1,025	$99K	0.1%	N/A	0.001%
2/20/2024	Readystate Asset Management LP	12,726	$1.23M	0.0%	-22.4%	0.007%
2/16/2024	Price T Rowe Associates Inc. MD	1,605,983	$154.85M	0.0%	+33.3%	0.853%
2/14/2024	Third Point LLC	385,000	$37.12M	0.6%	N/A	0.204%
2/14/2024	Iron Triangle Partners LP	200,000	$19.28M	2.5%	N/A	0.106%
2/14/2024	Altitude Crest Partners Inc.	114,042	$11M	7.4%	N/A	0.061%
2/14/2024	First Light Asset Management LLC	185,579	$17.89M	1.4%	+200.5%	0.099%
2/14/2024	Frontier Capital Management Co. LLC	442,456	$42.66M	0.4%	+2.6%	0.235%
2/14/2024	Bridgewater Associates LP	190,970	$18.41M	0.1%	+18.3%	0.101%
2/14/2024	Artia Global Partners LP	28,885	$2.79M	0.8%	-63.2%	0.015%
2/14/2024	Bellevue Group AG	325,776	$31.41M	0.5%	-6.9%	0.173%
2/14/2024	Avoro Capital Advisors LLC	4,300,000	$414.61M	5.7%	+11.7%	2.283%
2/14/2024	Lighthouse Investment Partners LLC	40,613	$3.92M	0.2%	N/A	0.022%
2/14/2024	Scout Investments Inc.	791,625	$76.33M	1.9%	-12.3%	0.420%
2/14/2024	Sectoral Asset Management Inc.	50,070	$4.83M	2.1%	-65.5%	0.027%
2/13/2024	Morningstar Investment Services LLC	44,602	$4.33M	0.0%	+109.3%	0.024%
2/13/2024	Pinebridge Investments L.P.	23,189	$2.24M	0.0%	+33.6%	0.012%
2/13/2024	Cibc World Markets Corp	270,242	$26.06M	0.1%	N/A	0.143%
2/13/2024	Gabelli Funds LLC	7,175	$0.69M	0.0%	-12.6%	0.004%
2/13/2024	Public Employees Retirement Association of Colorado	22,011	$2.12M	0.0%	+5,430.4%	0.012%
2/13/2024	1832 Asset Management L.P.	737,221	$71.08M	0.1%	+55.7%	0.391%
2/13/2024	Capital Research Global Investors	10,774,641	$1.04B	0.3%	+79.0%	5.720%
2/13/2024	Eisler Capital UK Ltd.	12,584	$1.21M	0.0%	N/A	0.007%
2/13/2024	First Trust Advisors LP	579,931	$55.92M	0.1%	+10.8%	0.308%
2/13/2024	Royal London Asset Management Ltd.	73,817	$7.12M	0.0%	+2.7%	0.039%
2/13/2024	Rafferty Asset Management LLC	96,599	$9.31M	0.0%	-2.2%	0.051%
2/13/2024	Rhenman & Partners Asset Management AB	282,500	$27.24M	2.7%	-25.7%	0.150%
2/13/2024	CIBC Asset Management Inc	6,034	$0.58M	0.0%	-6.9%	0.003%
2/13/2024	Jones Financial Companies Lllp	450	$43K	0.0%	N/A	0.000%
2/13/2024	APG Asset Management US Inc.	35,901	$3.46M	0.0%	N/A	0.019%
2/13/2024	California State Teachers Retirement System	280,920	$27.09M	0.0%	-1.2%	0.149%
2/12/2024	Eagle Asset Management Inc.	436,279	$42.07M	0.2%	-0.4%	0.232%
2/12/2024	Brown Brothers Harriman & Co.	266	$26K	0.0%	-69.3%	0.000%
2/12/2024	Bank of Nova Scotia	277,468	$26.75M	0.1%	+1.7%	0.147%
2/12/2024	Parnassus Investments LLC	1,849,348	$178.31M	0.4%	-20.9%	0.982%
2/12/2024	Comgest Global Investors S.A.S.	199,321	$19.22M	0.3%	+12.6%	0.106%
2/12/2024	TFO Wealth Partners LLC	4,059	$0.39M	0.0%	+912.2%	0.002%
2/12/2024	Treasurer of the State of North Carolina	104,083	$10.04M	0.0%	+6.2%	0.055%
2/12/2024	Weiss Asset Management LP	17,849	$1.72M	0.1%	N/A	0.009%
2/12/2024	Allianz Asset Management GmbH	38,044	$3.67M	0.0%	-15.2%	0.020%
2/12/2024	Stifel Financial Corp	49,676	$4.79M	0.0%	+9.9%	0.026%
2/12/2024	TD Asset Management Inc	191,030	$18.42M	0.0%	+10.3%	0.101%
2/12/2024	Parallel Advisors LLC	2,198	$0.21M	0.0%	-6.5%	0.001%
2/12/2024	Hsbc Holdings PLC	429,057	$41.33M	0.0%	-29.3%	0.228%
2/9/2024	Intech Investment Management LLC	25,168	$2.43M	0.0%	-13.6%	0.013%
2/9/2024	Primecap Management Co. CA	18,414,374	$1.78B	1.4%	+0.0%	9.776%
2/9/2024	Nomura Asset Management Co. Ltd.	377,771	$36.43M	0.2%	-1.1%	0.201%
2/9/2024	Orion Portfolio Solutions LLC	20,185	$2M	0.0%	-9.6%	0.011%
2/9/2024	SageView Advisory Group LLC	2,945	$0.26M	0.0%	N/A	0.002%
2/9/2024	Commerce Bank	36,569	$3.53M	0.0%	-7.7%	0.019%
2/9/2024	Franklin Resources Inc.	301,764	$29.10M	0.0%	-46.7%	0.160%
2/9/2024	Assetmark Inc.	12,249	$1.18M	0.0%	+107.3%	0.007%
2/9/2024	Clearbridge Investments LLC	270,843	$26.12M	0.0%	-37.2%	0.144%
2/9/2024	UBS Group AG	92,452	$8.91M	0.0%	-62.3%	0.049%
2/9/2024	PNC Financial Services Group Inc.	8,203	$0.79M	0.0%	-1.4%	0.004%
2/9/2024	BI Asset Management Fondsmaeglerselskab A S	8,543	$0.82M	0.0%	+174.8%	0.005%
2/9/2024	Dynamic Technology Lab Private Ltd	8,345	$0.81M	0.1%	N/A	0.004%
2/9/2024	Norges Bank	3,361,310	$324.10M	0.1%	N/A	1.784%
2/8/2024	ING Groep NV	210,000	$20.25M	0.2%	N/A	0.111%
2/8/2024	New Century Financial Group LLC	4,722	$0.46M	0.4%	N/A	0.003%
2/8/2024	Panagora Asset Management Inc.	26,418	$2.55M	0.0%	+4.6%	0.014%
2/8/2024	Fiera Capital Corp	654,867	$63.14M	0.2%	+1.0%	0.348%
2/8/2024	EFG Asset Management North America Corp.	69,616	$6.71M	1.3%	+3.4%	0.037%
2/8/2024	Beacon Pointe Advisors LLC	17,838	$1.72M	0.0%	-0.7%	0.009%
2/8/2024	Inceptionr LLC	2,757	$0.27M	0.2%	N/A	0.001%
2/8/2024	Thornburg Investment Management Inc.	170,802	$16.48M	0.2%	-38.1%	0.091%
2/8/2024	Torray Investment Partners LLC	14,668	$1.41M	0.2%	+3.1%	0.008%
2/8/2024	Janney Montgomery Scott LLC	8,688	$0.84M	0.0%	-3.1%	0.005%
2/8/2024	Vanguard Personalized Indexing Management LLC	9,301	$0.90M	0.0%	-14.4%	0.005%
2/8/2024	Mitsubishi UFJ Asset Management Co. Ltd.	83,599	$8.08M	0.0%	-0.4%	0.044%
2/8/2024	Westpac Banking Corp	2,087	$0.20M	0.0%	+54.4%	0.001%
2/8/2024	Moran Wealth Management LLC	2,350	$0.23M	0.0%	N/A	0.001%

Data available starting January 2016

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it develops Roctavian, an adeno associated virus vector, for the treatment of patients with severe hemophilia A. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has license and collaboration agreements with Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc. The company was incorporated in 1996 and is headquartered in San Rafael, California.

Today's Range

Now: $91.20

$91.00

$93.01

50 Day Range

MA: $87.76

$83.81

$92.22

52 Week Range

Now: $91.20

$76.02

$99.56

Volume

1,598,868 shs

Average Volume

1,355,438 shs

Market Capitalization

$17.21 billion

P/E Ratio

103.64

Dividend Yield

N/A

Beta

0.31

Who are the company insiders with the largest holdings of BioMarin Pharmaceutical?: BioMarin Pharmaceutical's top insider shareholders include:
Jean Jacques Bienaime (Director)
Jean Jacques Bienaime (CEO)
Henry J Fuchs (Insider)
Richard A Meier (Director)
Jeffrey Robert Ajer (EVP)
George Eric Davis (EVP)
Charles Greg Guyer (EVP)
Brian Mueller (CFO)
V Bryan Lawlis (Director)
Erin Burkhart (CAO)
Mark J Alles (Director)
Learn More about top insider investors at BioMarin Pharmaceutical.
Who are the major institutional investors of BioMarin Pharmaceutical?: BioMarin Pharmaceutical's top institutional investors include:
Sumitomo Mitsui Trust Holdings Inc. — 0.25%
AMI Asset Management Corp — 0.18%
Allspring Global Investments Holdings LLC — 0.05%
IFM Investors Pty Ltd — 0.02%
Rice Hall James & Associates LLC — 0.02%
Gateway Investment Advisers LLC — 0.01%
Learn More about top institutional investors of BioMarin Pharmaceutical stock.
Which major investors are selling BioMarin Pharmaceutical stock?: During the previous quarter, BMRN stock was sold by these institutional investors:
Assenagon Asset Management S.A.
EFG Asset Management Americas Corp.
State of Alaska Department of Revenue
Sumitomo Mitsui Trust Holdings Inc.
New Century Financial Group LLC
Park Avenue Securities LLC
Rice Hall James & Associates LLC
Banque Cantonale Vaudoise
During the previous year, company insiders that have sold BioMarin Pharmaceutical company stock include:
Jean Jacques Bienaime (Director)
Jean Jacques Bienaime (CEO)
Henry J Fuchs (Insider)
Richard A Meier (Director)
Jeffrey Robert Ajer (EVP)
George Eric Davis (EVP)
Learn More investors selling BioMarin Pharmaceutical stock.
Which major investors are buying BioMarin Pharmaceutical stock?: During the last quarter, BMRN stock was bought by institutional investors including:
AMI Asset Management Corp
Allspring Global Investments Holdings LLC
New England Research & Management Inc.
Gateway Investment Advisers LLC
Simplicity Wealth LLC
Capital Insight Partners LLC
Cannon Global Investment Management LLC
SteelPeak Wealth LLC